| A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking CE Teunissen, A Petzold, JL Bennett, FS Berven, L Brundin, M Comabella, ... Neurology 73 (22), 1914-1922, 2009 | 733 | 2009 |
| HLA-DR15 Haplotype and Multiple Sclerosis: A HuGE Review H Schmidt, D Williamson, A Ashley-Koch American journal of epidemiology 165 (10), 1097-1109, 2007 | 268 | 2007 |
| Associations of disease-modifying therapies with COVID-19 severity in multiple sclerosis S Simpson-Yap, E De Brouwer, T Kalincik, N Rijke, JA Hillert, C Walton, ... Neurology 97 (19), e1870-e1885, 2021 | 217 | 2021 |
| Use of altered informed consent in pragmatic clinical research RE McKinney Jr, LM Beskow, DE Ford, JD Lantos, J McCall, ... Clinical Trials 12 (5), 494-502, 2015 | 104 | 2015 |
| Consensus guidelines for CSF and blood biobanking for CNS biomarker studies CE Teunissen, H Tumani, JL Bennett, FS Berven, L Brundin, ... Multiple sclerosis international 2011, 2011 | 89 | 2011 |
| Impact of the COVID-19 pandemic on the health care of> 1,000 People living with multiple sclerosis: A cross-sectional study AC Vogel, H Schmidt, S Loud, R McBurney, FJ Mateen Multiple sclerosis and related disorders 46, 102512, 2020 | 75 | 2020 |
| COVID-19 in people with multiple sclerosis: a global data sharing initiative LM Peeters, T Parciak, C Walton, L Geys, Y Moreau, E De Brouwer, ... Multiple Sclerosis Journal 26 (10), 1157-1162, 2020 | 62 | 2020 |
| Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis KC Simon, H Schmidt, S Loud, A Ascherio Multiple Sclerosis Journal 21 (6), 703-709, 2015 | 44 | 2015 |
| Updated results of the COVID-19 in MS global data sharing initiative: anti-CD20 and other risk factors associated with COVID-19 severity S Simpson-Yap, A Pirmani, T Kalincik, E De Brouwer, L Geys, T Parciak, ... Neurology: Neuroimmunology & Neuroinflammation 9 (6), e200021, 2022 | 34 | 2022 |
| COVID-19 vaccination reactogenicity in persons with multiple sclerosis FBS Briggs, FJ Mateen, H Schmidt, KM Currie, HM Siefers, S Crouthamel, ... Neurology: Neuroimmunology & Neuroinflammation 9 (1), e1104, 2021 | 34 | 2021 |
| Rationale and design of the STEP for MS Trial: Comparative effectiveness of Supervised versus Telerehabilitation Exercise Programs for Multiple Sclerosis RW Motl, D Backus, WN Neal, G Cutter, L Palmer, R McBurney, H Schmidt, ... Contemporary clinical trials 81, 110-122, 2019 | 31 | 2019 |
| Dataflow representation of data analyses: Toward a platform for collaborative data science E Patterson, R McBurney, H Schmidt, I Baldini, A Mojsilović, KR Varshney IBM Journal of Research and Development 61 (6), 9: 1-9: 13, 2017 | 22 | 2017 |
| Perceptions and preferences regarding multiple sclerosis research among racial and ethnic groups DA Pimentel Maldonado, A Moreno, MJ Williams, L Amezcua, S Feliciano, ... International Journal of MS Care 23 (4), 170-177, 2021 | 20 | 2021 |
| First results of the COVID-19 in MS Global Data Sharing Initiative suggest anti-CD20 DMTs are associated with worse COVID-19 outcomes S Simpson-Yap, E De Brouwer, T Kalincik, N Rijke, J Hillert, C Walton, ... Multiple Sclerosis Journal 26 (3_SUPPL), 48-49, 2020 | 19 | 2020 |
| Epstein–Barr virus candidate genes and multiple sclerosis KC Simon, H Schmidt, S Loud, A Ascherio Multiple Sclerosis and Related Disorders 4 (1), 60-64, 2015 | 8 | 2015 |
| Associations between lifestyle behaviors and quality of life differ based on multiple sclerosis phenotype N Nag, M Yu, GA Jelinek, S Simpson-Yap, SL Neate, HK Schmidt Journal of Personalized Medicine 11 (11), 1218, 2021 | 7 | 2021 |
| Short commentary on ‘a consensus protocol for the standardization of cerebrospinal fluid collection and biobanking’ CE Teunissen, HT Tumani, JL Bennett, FS Berven, L Brundin, ... Multiple Sclerosis Journal 16 (2), 129-132, 2010 | 7 | 2010 |
| Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β S Simpson-Yap, A Pirmani, E De Brouwer, LM Peeters, L Geys, T Parciak, ... Multiple Sclerosis and Related Disorders 66, 104072, 2022 | 6 | 2022 |
| Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables? T Bharadia, J Vandercappellen, T Chitnis, P Eelen, B Bauer, G Brichetto, ... Multiple Sclerosis Journal–Experimental, Translational and Clinical 8 (2 …, 2022 | 6 | 2022 |
| The Multiple Sclerosis Data Alliance Catalogue: enabling web-based discovery of metadata from real-world multiple sclerosis data sources L Geys, T Parciak, A Pirmani, R McBurney, H Schmidt, T Malbaša, ... International journal of MS care 23 (6), 261-268, 2021 | 5 | 2021 |
